GlobeNewswire by notified

Kitron: Q3 2023 - Rekordomsetning for tredje kvartal og sterk lønnsomhet

Del

(2023-10-25) Kitron rapporterer i dag rekordomsetning for tredje kvartal og sterk lønnsomhet, med marginer stabilt over selskapets langsiktige mål.

Kitrons driftsinntekter for tredje kvartal var 179,2 millioner euro, sammenlignet med 165,5 millioner i fjor. Veksten var spesielt sterk innenfor markedssektoren Elektrifisering.

Driftsresultatet (EBIT) i tredje kvartal var 16,2 millioner euro, sammenlignet med 11,5 millioner i fjor. EBITDA var 20,7 millioner euro, sammenlignet med 15,8 millioner i fjor.

Ordrereserven endte på 502 millioner euro, en økning på 10 prosent sammenlignet med fjoråret, noe som reflekterer fortsatt sterk etterspørsel. Den høyeste veksten var i markedssektorene Elektrifisering og Forsvar/Luftfart. Ordrereserven er imidlertid lavere enn i forrige kvartal fordi en gradvis bedre situasjon for elektronikkomponenter har redusert ledetidene.

Peter Nilsson, Kitrons konsernsjef, kommenterer:
– I tredje kvartal 2023 har vi nådd en ny milepæl for våre resultater med rekordsalg for tredje kvartal. Kvartalet viser vår stødighet og kapasitet, og demonstrerer igjen en periode preget av robust lønnsomhet og det fjerde kvartalet på rad med mer enn 9 prosent EBIT-margin. Som tidligere meldt har vi forventet at ordrereserven vår vil normalisere seg på grunn av den gradvis bedre situasjonen for elektronikkomponenter. Utsiktene våre holder seg imidlertid stabile, noe som indikerer en trend mot vekst i stedet for nedgang.

Lønnsomheten uttrykt som EBIT-margin var 9,0 prosent i tredje kvartal, sammenlignet med 6,9 prosent i samme kvartal i fjor.

Resultat etter skatt ble 9,7 millioner euro, sammenlignet med 7,5 millioner i samme kvartal året før. Dette tilsvarer et resultat per aksje på 0,05 euro, opp fra 0,04 i fjor.

Stabil kapitaleffektivitet
Kontantstrøm fra driften i tredje kvartal var 5,0 millioner euro, sammenlignet med 14,6 millioner i tredje kvartal 2022. Kontantstrømmen hittil i år var 24,4 millioner euro, sammenlignet med 7,7 millioner i 2022.

Netto arbeidskapital var 200 millioner euro, en økning på 19 prosent sammenlignet med samme kvartal i fjor. Netto arbeidskapital i prosent av omsetningen var 26,7 prosent mot 25,8 prosent i fjor. Kapitaleffektiviteten er stabilisert.

Utsikter
For 2023 gjentar Kitron sine utsikter fra rapporten for andre kvartal og forventer inntekter mellom 750 og 800 millioner euro med et driftsresultat (EBIT) mellom 65 og 75 millioner euro.

Vedlagt i PDF er kvartalsrapport og presentasjon. Kvartalsrapporten presenteres i dag kl. 14.00. Presentasjonen blir holdt av konsernsjef Peter Nilsson og finansdirektør Cathrin Nylander, og blir distribuert via webcast på følgende lenke:

https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20231025_2

For ytterligere informasjon, vennligst kontakt:
Peter Nilsson, konsernsjef, tlf. +47 948 40 850
Cathrin Nylander, finansdirektør, tlf.: +47 900 43 284 E-post: investorrelations@kitron.com

Kitron er et ledende skandinavisk foretak innen produksjon av elektronikk og relaterte tjenester for sektorene Konnektivitet, Elektrifisering, Industri, Medisinsk utstyr og Forsvar/Luftfart. Konsernet har virksomhet i Norge, Sverige, Danmark, Litauen, Tyskland, Polen, Tsjekkia, India, Kina og USA. Kitron har rundt 3.200 ansatte, og driftsinntektene var 641 millioner euro i 2022. www.kitron.com

Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12


Vedlegg

Hvis du vil se dette innholdet fra www.globenewswire.com, gi ditt samtykke øverst på denne siden.
Hvis du vil se dette innholdet fra ml-eu.globenewswire.com, gi ditt samtykke øverst på denne siden.

Om GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg pressemeldinger fra GlobeNewswire by notified

Registrer deg med din e-postadresse under for å få de nyeste sakene fra GlobeNewswire by notified på e-post fortløpende. Du kan melde deg av når som helst.

Siste pressemeldinger fra GlobeNewswire by notified

Exhibition World Bahrain Secures "World’s Leading New Exhibition and Convention Centre 2023" Award at World Travel Awards 20233.12.2023 11:00:00 CET | Press release

DUBAI, United Arab Emirates, Dec. 03, 2023 (GLOBE NEWSWIRE) -- Exhibition World Bahrain (EWB), the Middle East’s newest and largest exhibition and convention centre, is proud to announce securing the “World’s Leading New Exhibition and Convention Centre 2023” at the World Travel Awards 2023. The award accolade was presented to Dr. Nasser Qaedi, the CEO of Bahrain Tourism and Exhibitions Authority (BTEA), during the World Travel Awards 2023 Grand Final Gala Ceremony, which took place at Burj Al Arab in Dubai, UAE, on December 1, 2023, in the presence of HE Philip Joseph Pierre, the prime minister of Saint Lucia, tourism ministers, and travel elites across the globe. Exhibition World Bahrain captured the highest number of votes, clinching the internationally recognised award from Bharat Mandapam, India, and Tākina Wellington Convention and Exhibition centre, New Zealand. With this unrivalled win, the Kingdom of Bahrain has further cemented its reputation as the leading global hub for the

Merus Presents Interim Data on MCLA-129 at ESMO Asia Congress 20233.12.2023 02:40:00 CET | Press release

MCLA-129 in combination with chemotherapy in 2L+ EGFRm NSCLC planned to initiate 1Q24 UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 02, 2023 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, “the Company”, “we”, or “our”), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced updated interim clinical data on MCLA-129 from ongoing expansion cohorts in non-small cell lung cancer (NSCLC) and in previously treated head and neck squamous cell carcinoma (HNSCC) were presented at the European Society for Medical Oncology (ESMO) Asia Congress 2023. “MCLA-129 is a very active drug in EGFRm NSCLC and we’re planning a focused investment to evaluate MCLA-129 in combination with chemotherapy, which we expect to start early in 2024,” said Bill Lundberg M.D., President, Chief Executive Officer of Merus. “We are in a fortunate position to have a strong balance sheet. We also recognize the importance of be

CASGEVY Gets Bahrain approval for treatment, marking it second country in the world2.12.2023 18:59:21 CET | Press release

MANAMA, Bahrain, Dec. 02, 2023 (GLOBE NEWSWIRE) -- Bahrain has become the second country in the world and the first in the Middle East to approve the use of CASGEVY (exagamglogene autotemcel) for the treatment of patients with sickle cell disease and transfusion-dependent beta-thalassemia. The treatment was developed by Vertex Pharmaceuticals and CRISPR Therapeutics, after conducting a series of successful clinical trials in the UK, US, France, Italy, and Germany, among others. Following the UK MHRA’s authorisation to use CASGEVY, Bahrain is the second country in the world and the first in the region to approve this treatment. This extraordinary development opens up new possibilities for medical advancements and reinforces Bahrain's commitment to pioneering healthcare solutions, offering a better quality of life for patients with these blood disorders. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a revolutionary gene-editing technique that holds immense potenti

Scatec at COP28: Accelerating renewable energy transition from Egypt to South Africa2.12.2023 14:01:22 CET | Press release

Dubai, 2 December 2023: This week, Scatec ASA, a leading renewable energy company, is actively engaging in the UN Climate Change Conference in Dubai (COP28). Our focus is to underscore renewable energy as an unequivocal solution to climate change and emphasise the critical need for increased green energy investments in emerging markets. COP28 serves as a pivotal platform for global stakeholders to reinforce commitments aimed at averting catastrophic consequences of climate change. Scatec aligns with climate experts in stressing the urgency of the situation and the imperative to continue advancing towards the objectives outlined in the Paris Agreement. There's no time to waste, and collective progress is crucial for safeguarding our planet's future. “We are at COP28 to highlight the key role renewable energy must play in our energy future, "At COP28, our focus is on underscoring the crucial role renewable energy must assume in shaping our energy future, particularly in emerging markets,

Unplugged Performance Introduces UP INVINCIBLE®: A Game-Changer for Tesla Cybertruck Enthusiasts2.12.2023 05:06:20 CET | Press release

HAWTHORNE, Calif., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Unplugged Performance, the industry leader in performance upgrades for Tesla vehicles, debuts a new chapter in Tesla tuning with the arrival of their UP INVINCIBLE® product line. UP INVINCIBLE® is tailored exclusively for Tesla Cybertruck owners who want to push the limits of on-road and off-road performance. The unveiling took place at Unplugged Performance’s celebratory afterparty for Tesla's highly anticipated Cybertruck delivery event on November 30th. Hosted at the company's headquarters in Hawthorne, California, neighboring Tesla Design Studio, SpaceX, and Starlink, the event drew a capacity crowd, reflecting the immense enthusiasm for this innovative product range. UP INVINCIBLE® represents a concerted effort to harness and amplify the rugged DNA of the Cybertruck, making it even more robust and capable in a variety of challenging environments. During the event, Ben Schaffer, CEO of Unplugged Performance, presented an extensiv